Head-to-head · Cost-Efficiency Index
Magnolia Regenerative Medicine vs ARSYNL Rx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Magnolia Regenerative Medicine
Readers in one of the 26 states it treats who want a titration plan priced per step and will not need to cancel by email.
Visit Magnolia Regenerative MedicineARSYNL Rx
Cost-first shoppers who want a needle-free tirzepatide hypospray option alongside standard compounded injections, from a veteran-founded telehealth brand.
Visit ARSYNL RxThe verdict
Magnolia Regenerative Medicine takes it, leading the Cost-Efficiency Index 57 to 56. Magnolia Regenerative Medicine charges $119 a month for compounded semaglutide and $199 for tirzepatide once you reach the intake, advertises $99 and $179 that are really three-month prepay rates, and publishes a cancellation address that cannot receive mail. ARSYNL Rx still earns a C — Cost-first shoppers who want a needle-free tirzepatide hypospray option alongside standard compounded injections, from a veteran-founded telehealth brand.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Magnolia Regenerative Medicine.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Magnolia Regenerative Medicine | ARSYNL Rx |
|---|---|---|
| Cost-Efficiency Index | 57/100 | 56/100 |
| Semaglutide / mo | $119.00/month month-to-month (the advertised $99 is a three-month prepay at the flat minimum dose) | $233/mo (starting dose, compounded) |
| Tirzepatide / mo | $199.00/month month-to-month (the advertised $179 is a three-month prepay at the flat minimum dose) | $233/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $1,428 | $2,796 |
| Tirzepatide / yr (modeled) | $2,388 | $2,796 |
| Coverage | 26 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #317 | #320 |
Magnolia Regenerative Medicine
57/100Where the value is
- Publishes an explicit 26-state telehealth list rather than an unverifiable nationwide claim
- Prices a new-patient titration plan separately from a continuing-patient plan, so the cost of stepping up a dose is visible rather than assumed
- Runs two physical clinics and says so, which is unusual for a compounded GLP-1 seller
The tradeoffs
- The advertised "starting at $99" and "starting at $179" are three-month prepay figures; the month-to-month rates are $119 and $199, and the arithmetic behind that is on the site itself
- A first-time patient cannot buy the advertised price at all — answering that this is your first time yields titration plans at $119 and $199 a month
ARSYNL Rx
56/100Where the value is
- Genuinely veteran-founded — the About page names founder Arron Glysch and recounts his own hair-loss experience while deployed overseas
- Offers a needle-free tirzepatide HypoSpray with six published dose protocols (10mg-60mg total/month)
- All three GLP-1 SKUs are stated to already include the consultation and shipping in the quoted price
The tradeoffs
- No compounding pharmacy is named on any product page checked
- No individual medical director or prescriber is named anywhere accessible — only 'U.S. board certified physicians' as a category
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.